Abstract
Objectives: To compare treatment effect estimates obtained from a regression discontinuity (RD) design with results from an actual randomized controlled trial (RCT). Study Design and Setting: Data from an RCT (EVIDENT), which studied the effect of an Internet intervention on depressive symptoms measured with the Patient Health Questionnaire (PHQ-9), were used to perform an RD analysis, in which treatment allocation was determined by a cutoff value at baseline (PHQ-9 = 10). A linear regression model was fitted to the data, selecting participants above the cutoff who had received the intervention (n = 317) and control participants below the cutoff (n = 187). Outcome was PHQ-9 sum score 12 weeks after baseline. Robustness of the effect estimate was studied; the estimate was compared with the RCT treatment effect. Results: The final regression model showed a regression coefficient of -2.29 [95% confidence interval (CI): -3.72 to -.85] compared with a treatment effect found in the RCT of -1.57 (95% CI: -2.07 to -1.07). Conclusion: Although the estimates obtained from two designs are not equal, their confidence intervals overlap, suggesting that an RD design can be a valid alternative for RCTs. This finding is particularly important for situations where an RCT may not be feasible or ethical as is often the case in clinical research settings.
| Original language | English |
|---|---|
| Pages (from-to) | 94-102 |
| Number of pages | 9 |
| Journal | Journal of Clinical Epidemiology |
| Volume | 82 |
| DOIs | |
| Publication status | Published - Feb 2017 |
| Externally published | Yes |
Keywords
- regression discontinuity design
- randomized controlled trials
- causal inference
- nonrandom group assignment
- depression
- PHQ-9
Fingerprint
Dive into the research topics of 'The regression discontinuity design showed to be a valid alternative to a randomized controlled trial for estimating treatment effects'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver